Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carolyn Bieber"'
Autor:
Gerardo Colón-Otero M.D., Sherry King, Vandelyn Smith, Carolyn Bieber, Julia Crook, Lawrence A. Solberg, Robert Shannon, Edith A. Perez
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2 (2008)
A prospective analysis of women with terminal breast cancer admitted to CHNE from November 2006-August 2007 evaluated anecdotal observations that African American (AA) women are likelier than Caucasian women to evidence loco-regional recurrences (LRR
Externí odkaz:
https://doaj.org/article/6359c3a7be974713ac1a558b69dfc86e
Autor:
Carolyn Bieber, Michael E. Menefee, Vahab Fatourechi, Anne M. Traynor, Keith C. Bible, Jill K. Burton, Joseph Rubin, Ian D. Hay, Nina J. Karlin, Charles Erlichman, Robert C. Smallridge, Kevin P. Webster, Julian R. Molina, Kostandinos Sideras, Vera J. Suman, William J. Maples, Bryan McIver, Boon Cher Goh, Patrick J. Flynn, Crescent R. Isham, Pamela Jo Harris, John C. Morris
Pazopanib is a small molecule inhibitor of kinases principally including vascular endothelial growth factor receptors-1, -2, and -3; platelet-derived growth factor receptors-α and -β; and c-Kit. We previously reported a tumor response rate of 49% i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f90af02edd6a9671e52efb9a879d4c
https://europepmc.org/articles/PMC4010705/
https://europepmc.org/articles/PMC4010705/
Autor:
Wan-Teck Lim, Andrea K. Kukla, Nina J. Karlin, Julian R. Molina, Keith C. Bible, Vera J. Suman, Robert C. Smallridge, Charles Erlichman, Kevin P. Webster, Boon Cher Goh, Anne M. Traynor, Priya Kumar, Jill K. Burton, Pamela Jo Harris, Carolyn Bieber, Michael E. Menefee, Ayoko R. Bossou, William J. Maples, Crescent R. Isham
Publikováno v:
The Journal of clinical endocrinology and metabolism. 97(9)
Pazopanib, an inhibitor of kinases including vascular endothelial growth factor receptor, demonstrated impressive activity in progressive metastatic differentiated thyroid cancer, prompting its evaluation in anaplastic thyroid cancer (ATC).Preclinica
Autor:
W. J. Maples, V. J. Suman, Hui Tang, Robert C. Smallridge, C. Erlichman, K. C. Bible, P. J. Flynn, Kostandinos Sideras, Anne M. Traynor, K. P. Webster, Carolyn Bieber, B. C. Goh, Jill K. Burton, J. C. Morris rd, Julian R. Molina, Michele Marinò, J. Rubin, B. McIver, Michael E. Menefee, S. P. Ivy
Publikováno v:
L'Endocrinologo. 11:235-236
Autor:
Jill K. Burton, Crescent R. Isham, Kevin P. Webster, Ayoko R. Bossou, Pamela Jo Harris, Carolyn Bieber, Charles Erlichman, Priya Kumar, Wan-Teck Lim, VJ Suman, Keith C. Bible, Robert C. Smallridge, William J. Maples, Nina J. Karlin, Julian R. Molina, Anne M. Traynor, Andrea K. Kukla, Boon Cher Goh, Michael E. Menefee
Publikováno v:
Journal of Clinical Oncology. 30:5544-5544
5544 Background: Pazopanib, an orally bioavailable multitargeted inhibitor of kinases including VEGF-R, demonstrated impressive activity in metastatic differentiated thyroid cancer (49% durable RECIST PRs) and promising preclinical activity in anapla
Autor:
S. P. Ivy, Carolyn Bieber, Robert C. Smallridge, Jill K. Burton, VJ Suman, Keith C. Bible, Julian R. Molina, Michael E. Menefee, William J. Maples, Charles Erlichman
Publikováno v:
Journal of Clinical Oncology. 27:3521-3521
3521 Background: Systemic therapies have had little impact on the outcomes of patients with advanced differentiated thyroid cancers. Methods: A three-outcome one-stage Phase II trial was conducted to assess the anti-tumor activity and toxicities of t
Autor:
Carolyn Bieber, Sherry King, Lawrence A. Solberg, Edith A. Perez, Gerardo Colon-Otero, Vandelyn Smith, Julia E. Crook, Robert P. Shannon
Publikováno v:
Clinical Medicine. Oncology
Clinical Medicine Insights: Oncology, Vol 2 (2008)
Clinical Medicine Insights: Oncology, Vol 2 (2008)
A prospective analysis of women with terminal breast cancer admitted to CHNE from November 2006-August 2007 evaluated anecdotal observations that African American (AA) women are likelier than Caucasian women to evidence loco-regional recurrences (LRR